These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1411195)

  • 21. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
    Kuriyama S; Hosoya T; Sakai O
    Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rheumatoid arthritis, obliterating bronchiolitis and D-penicillamine. Apropos of a new case with ultrastructural examination and review of the literature].
    Geraads A; Brambilla E; Hohn B; Piton JL; Blanc-Jouvan F; Kamel A
    Poumon Coeur; 1983; 39(5):257-62. PubMed ID: 6657554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nail-changes induced by penicillamine.
    Bjellerup M
    Acta Derm Venereol; 1989; 69(4):339-41. PubMed ID: 2568058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveys of the epidemiological team of the French Rheumatology Society (RESFR) on the prescription of D-penicillamine in the treatment of rheumatoid polyarthritis].
    Carter H; Chevallier J; Ghoussoub K; Paolaggi JB
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):331-9. PubMed ID: 3738396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL; Mewis L; Stewart RH
    Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D; Kommerell G
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pemphigus herpetiformis following D-penicillamine in a patient with HLA B8].
    Weltfriend S; Ingber A; David M; Sandbank M
    Hautarzt; 1988 Sep; 39(9):587-8. PubMed ID: 2972666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse fasciculations induced by D-penicillamine.
    Pinals RS
    J Rheumatol; 1983 Oct; 10(5):809-10. PubMed ID: 6644706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.